期刊文献+

糖尿病性视网膜病变发病机制研究进展 被引量:59

An overview of the pathogenesis of diabetic retinopathy
下载PDF
导出
摘要 糖尿病性视网膜病变(DR)是糖尿病最常见和最严重的微血管并发症之一,DR的病理特征为视网膜新生血管形成和BRB破坏,它是糖尿病患者视力丧失的主要原因。高血糖是糖尿病并发症发生和发展的重要危险因素,而糖尿病最终如何导致DR发病的机制十分复杂。长期的高血糖症导致氧化酶损伤,微血栓形成,细胞粘附分子活化,白细胞郁积和细胞因子活化,继之,缺氧调节的生长因子的表达增加和细胞因子的产生。在这个机制中起主要作用的因子为VEGF、IGF-1、TNF-α、IL-1β、FGF等。多种因子相互作用引起视网膜新生血管形成和血—视网膜屏障(BRB)破坏在DR的发生和发展中起着关键作用。本文通过文献回顾,综述了糖尿病性视网膜病变发病机制的研究进展。 Diabetic retinopathy (DR) is one of the most common and the most severe complications of diabetes mellitus (DM), and it may induce blindness. The pathology characteristic of DR is the breakdown of the blood-retinal barrier and neovascularisation. Hyperglycaemia is an important factor in the development and progression of this disease. The pathogenesis of DR is very complex. Chronic hyperglycaemia leads to oxidative injury, microthrombi formation, cell adhesion molecule activation, leukostasis and cytokine activation. Then ischaemia-mediated overexpression of growth factors and cytokine occurs, in which VEGF, IGF-1, TNF-α, IL-1β, FGF play impotant roles. The breakdown of the blood-retinal barrier and neovascularisation induced by the interaction of many factorscause a great effect on the development and progression of DR. The research progress of the pathogenesis of DR is summarized in the present paper.
出处 《国际眼科杂志》 CAS 2005年第6期1239-1242,共4页 International Eye Science
关键词 糖尿病性视网膜病变 血-视网膜屏障破坏 视网膜新生血管形成 diabetic retinopathy neovascularisation breakdown of blood-retinal barrier
  • 相关文献

参考文献2

二级参考文献11

  • 1Dorey CK, Aouididi S, Reynaud X, Dvorak HF, Brown LF. Correlation of vascular permeability factor/vascular endothelial growth factor with extraretinal neovascularization in the rat. Arch Ophthalmol, 1996; 114:1210
  • 2Sato Y, Kanno S, Oda N, Abe M, Ito M, Shitara K, Shibuya M. Properties of two VEGF receptors, Flt-1 and KDR in signal transduction. Ann NY Acad Sci, 2000;902:201
  • 3Kvanta A, Shen WY, Sarman S, Seregard S, Steen B, Rakoczy E. Matrix metalloproteinase (MMP) expression in experimental choroidal neovascularization. Curr Eye Res, 2000;21(3):684-690
  • 4Lutty GA, McLeod DS, Merges C, Diggs A, Plouet J. Localization of vascular endothelial growth factor in human retina and choroid. Arch Ophthalmol,1996;114:791
  • 5Saghizadeh M, Brown DJ, Castellon R, Chwa M, Huang GH, Ljubimova JY,Rosenberg S, Spirin KS, Stolitenko RB, Adachi W, Kinoshita S, Murphy G,Windsor L J, Kenney MC, Ljubimov AV. Overexpression of matrix metalloproteinase-10 and matrix metalloproteinase-3 in
  • 6Tolentino MJ, Miller JW, Gragoudas ES, Chatzistefanou K, Ferrara N,Adamis AP. vascular endothelial growth factor is sufficient to produce iris neovascularization and neovascular glaucoma in a nonhuman primate. Arch Ophthalmol, 1996; 114:1219
  • 7Simorre-Pinatel V, Guerrin M, Chollet P, Penary M, Clamens S, Malecaze F, Plouet J. Vascultrpin-VEGF stimulates retinal capillary endothelial cells through an autocrine pathway. Invest Ophthalmol Vis Sci, 1994; 35(9):3393
  • 8Okamoto N, Tobe T, Hackett SF, Ozaki H, Vinores MA, LaRochelle W, Zack DJ, Campochiaro PA. Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization.Am J Pa
  • 9郭立新,汪恕萍.基质金属蛋白酶与糖尿病血管病变[J].国外医学(内分泌学分册),2000,20(3):120-123. 被引量:3
  • 10宋鄂,李婷钰,徐琪,王心蕊,吴家祥.糖尿病大鼠视网膜中血管内皮生长因子的表达(英文)[J].国际眼科杂志,2003,3(3):9-12. 被引量:2

共引文献40

同被引文献588

引证文献59

二级引证文献314

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部